The Management of Patients with Advanced Motor Neuron Disease

Chinese Medical Journal (Taipei)

Volumn 61, Issue 3, 1998, Pages 141-145

  Wu, Pin Yuan ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hospice care; Motor neuron disease; Palliative care; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HOSPICE CARE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MOTOR NEURON DISEASE; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NUTRITIONAL SUPPORT; PALLIATIVE CARE; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 2442497401     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Williams DW, Windebank AJ. Motor neuron disease. Mayo Clin Proc 1991;66:55-82.
2. Annegers JF, Appel SH, Lee JRJ, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris county Texas 1985-1988. Arch Neurol 1991;48:589-93.
3. Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PL, Marsh G, Perl DP. Rising mortality from motor neuron disease in the USA, 1962-84. Lancet 1989;i:710-2.
4. Appel SH, Stockton-Appel V, Stewrd SS, Kerman RH. Amyotrophic lateral sclerosis associated clinical disorder and immunologic evaluation. Arch Neurol 1986;43:234-8.
5. Roelofs-Iverson RA, Mulder DW, Elveback LR, Kurland LT, Molgaard CA. ALS and heavy metals: a pilot case-control study. Neurology 1984;34:393-6.
6. Mulder DW, Howard FM. Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc 1976;51: 537-41.
7. Rowland LP. Riruzole for the treatment of amyotrophic lateral sclerosis - too soon to tell? New Engl J Med 1994;330:636-7.
8. Smith LG. Improvement of patients with amyotropic lateral sclerosis given ceftriaxone. Lancet 1992;339:1417.
9. American Academy of Neurology Ethics and Humanities Subcommittee. Palliative care in neurology. Neurology 1996;46:870-2.
10. Li TM, Alberman E, Swash M. Morbidity and mortality in motor neurone disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analysis. J Neurol Neurosurg Psychiat 1985;48: 320-7.
11. Kurland LT, Kurtzke JF, Goldberg ID. In: Epidemiology of Neurologic and Sense Organ Disorders. Vital and Health Stastistics Monographs. American Public Health Association. Cambridge, MA: Harvard University Press, 1973:108.
12. O'Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. Br Med J 1992;304:471-3.
13. Schiffer D, Brignolio F, Chio A, Leone M, Rosso MG. A study of prognostic factors in motor neurone disease. Adv Exp Med Biol 1987;209:255-63.
14. Tsai CP, Lin KP, Liao KK, Wang SJ, Wang V, Kao KP, Wu ZA. Immunosuppressive treatment in lower motor neuron syndrome with autoantibodies against GM1 ganglioside. Eur Neurol 1993;33:446-9.
15. Newrick PG, Langton-Hewer R. Motor neurone disease: can we do better? A study of 42 patients. Br Med J 1984;289: 539-42.
16. Noris FH, Smith RA, Denys EH. Motor neurone disease: toward better care. Br Med J 1985;291:259-62.
17. Howard RS, Wiles CM, Loh L. Respiratory complications and their management in motor neuron disease. Brain 1989;112:1155-70.
18. Silverstein MD, Stocking CB, Antel JP, Beckwith J, Roos RP, Siegler M. Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc 1991;66:906-13.
19. Newrick PG, Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiat 1985;48:838-40.